Loading…
eXoZymes, Inc. is projected to rise to $10.25 by 2027, a +47% move from its current price of $6.97. EXOZ is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $6.66 | $6.97 | $7.30 | +0.03% |
| Jul 15 | $6.53 | $6.97 | $7.45 | +0.07% |
| Jul 16 | $6.44 | $6.98 | $7.56 | +0.10% |
| Jul 17 | $6.36 | $6.98 | $7.66 | +0.13% |
| Jul 18 | $6.29 | $6.98 | $7.74 | +0.17% |
| Jul 19 | $6.23 | $6.98 | $7.82 | +0.20% |
| Jul 20 | $6.18 | $6.99 | $7.90 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.18 | $6.99 | $7.90 | +0.24% |
| Week 2 | $5.89 | $7.00 | $8.33 | +0.47% |
| Week 3 | $5.68 | $7.02 | $8.68 | +0.71% |
| Week 4 | $5.51 | $7.04 | $8.99 | +0.95% |
| Week 5 | $5.36 | $7.05 | $9.28 | +1.19% |
| Week 6 | $5.23 | $7.07 | $9.55 | +1.43% |
| Week 7 | $5.12 | $7.09 | $9.80 | +1.67% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing.
The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
EXOZ is the stock trading under the symbol EXOZ. The current price is $7.08, with a market capitalization of $65.71M and a market rank of 4456.
The near-term forecast for 2026 shows a neutral outlook, with an average price of $7.08, a low of $6.33, a high of $10.13, and an ROI of 0; sentiment is NEUTRAL.
Beyond 2026, the forecast depicts a bullish trajectory with rising averages and ROIs, including 2027 avg $10.27 and 2029 avg $12.13, culminating in a long-term rise to $48.81 average by 2050, supported by progressively higher upside across the years.
A major floor 39.7% below — a decisive break under it would weaken the trend.
The nearest floor, 9.2% below — buyers have tended to step in here.
The nearest ceiling, 41.2% above — a clean break opens room to run.
A major ceiling 67.9% above — clearing it would confirm fresh momentum.
Key EXOZ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EXOZ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.47 | Sell | $7.40 | Sell |
| MA 10 | $7.92 | Sell | $7.64 | Sell |
| MA 20 | $7.67 | Sell | $7.90 | Sell |
| MA 50 | $8.83 | Sell | $8.51 | Sell |
| MA 100 | $8.84 | Sell | $9.16 | Sell |
| MA 200 | $10.85 | Sell | $10.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.70 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -98.12 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -9.48 | Sell |
| Bollinger %B (20,2) | 0.20 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.60 | Sell |
| Awesome (5,34) | -0.87 | Sell |
| Ultimate (7,14,28) | 18.99 | Buy |
| Momentum (10) | -0.43 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 6.96 | Buy |
| ADX (14) | 18.92 | Neutral |
| ATR (14) | 0.32 | Info |
Sentiment: NEUTRAL. RSI(14) is 40. The 50-day simple moving average is $8.89 and the 200-day simple moving average is $10.89.
Support is at $6.33 and resistance is at $9.91. The 30-day trading range spans from $5.17 to $9.70.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.33 | $6.97 | $9.98 | 0% | Neutral | |
| $7.63 | $10.25 | $14.83 | +47% | Bullish | |
| $7.47 | $10.56 | $16.18 | +52% | Bullish | |
| $8.20 | $12.11 | $19.39 | +74% | Bullish | |
| $7.91 | $12.15 | $20.17 | +74% | Bullish | |
| $7.10 | $11.31 | $19.37 | +62% | Bullish | |
| $7.79 | $12.83 | $22.59 | +84% | Bullish | |
| $7.74 | $13.17 | $23.79 | +89% | Bullish | |
| $9.94 | $17.48 | $32.29 | +151% | Bullish | |
| $12.02 | $21.78 | $41.11 | +213% | Bullish | |
| $11.40 | $23.92 | $49.26 | +243% | Bullish | |
| $23.16 | $51.46 | $118.35 | +638% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $6.33 | $6.97 | $8.26 | +0.00% |
| August 2026 | $5.85 | $7.04 | $8.79 | +1.02% |
| September 2026 | $5.90 | $7.19 | $9.14 | +2.08% |
| October 2026 | $5.58 | $6.87 | $8.86 | -4.46% |
| November 2026 | $5.61 | $6.97 | $9.11 | +1.43% |
| December 2026 | $6.03 | $7.55 | $9.98 | +8.33% |
Click any year to see its month-by-month EXOZ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, EXOZ could reach as high as $9.98, with a base case around $6.97 and support toward $6.33 — roughly 0% from $6.97. A consolidation phase looks the most probable path here.
Expect EXOZ to range from $7.63 to $14.83 through 2027. The $10.25 average target implies a +47% move from current prices. That is up +47% on the projected 2026 average. Momentum favours further upside here.
The EXOZ price prediction for 2028 points to an average of $10.56 (low $7.47, high $16.18) — a potential gain of +52% on today's $6.97. Buyers look set to stay in control over this stretch.
In 2029, EXOZ is projected to trade between $8.20 and $19.39, averaging $12.11 — a potential gain of +74% from today's $6.97. That is up +15% on the projected 2028 average. Momentum favours further upside here.
eXoZymes, Inc.'s 2030 outlook centres on $12.15, within a $7.91 to $20.17 range. That is up 0% on the projected 2029 average. That marks a +74% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, EXOZ could reach as high as $19.37, with a base case around $11.31 and support toward $7.10 — roughly +62% from $6.97. Momentum favours further upside here.
Expect EXOZ to range from $7.79 to $22.59 through 2032. The $12.83 average target implies a +84% move from current prices. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The EXOZ price prediction for 2033 points to an average of $13.17 (low $7.74, high $23.79) — a potential gain of +89% on today's $6.97. Momentum favours further upside here.
In 2034, EXOZ is projected to trade between $9.94 and $32.29, averaging $17.48 — a potential gain of +151% from today's $6.97. That is up +33% on the projected 2033 average. Buyers look set to stay in control over this stretch.
eXoZymes, Inc.'s 2035 outlook centres on $21.78, within a $12.02 to $41.11 range. That is up +25% on the projected 2034 average. That marks a +213% change versus current levels. Momentum favours further upside here.
By 2040, EXOZ could reach as high as $49.26, with a base case around $23.92 and support toward $11.40 — roughly +243% from $6.97. Buyers look set to stay in control over this stretch.
Expect EXOZ to range from $23.16 to $118.35 through 2050. The $51.46 average target implies a +638% move from current prices. That is up +115% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in EXOZ today (≈ 143.472023 EXOZ) could be worth
$7,382.54
+$6,382.54 (+638%) by 2050 · US Dollar
Based on the average projected EXOZ price of $51.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EXOZwould be worth at today's price.
$1,000 invested in EXOZ on Jul 10, 2025 (≈ 99.800395 EXOZ) would be worth
$695.61
-$304.39 (-30.4%) today · 0.70× · US Dollar
Based on a EXOZ entry price of $10.02 vs. today's $6.97.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.48 | $821.93 | -17.8% |
| 1 month ago | $7.72 | $902.85 | -9.7% |
| 3 months ago | $11.7 | $595.73 | -40.4% |
| 6 months ago | $9.49 | $734.46 | -26.6% |
| 1 year ago | $10.02 | $695.61 | -30.4% |
| All time (1.7y) ago | $8.65 | $805.78 | -19.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EXOZ forecast.
Our base-case forecast reaches $14.00 around 2034.
Implied market cap at $14.00: $129.94M
The multi-year forecast settles into a bullish trend after 2026. The 2027 average is $10.27 with a max of $14.95 and ROI of 45, followed by 2028 average $10.61 (max $16.37, ROI 49.8) and 2029 average $12.13 (max $19.58, ROI 71.4).
In 2030 the average is $12.04 with a max of $20.17 and ROI of 70.1, continuing with 2031 average $11.13 and 2032 average $12.52, both bullish. The 2034 forecast shows an average of $16.91 and a max of $31.60 (ROI 138.8%), and 2035 yields an average of $21.21 with a max of $40.48 (ROI 199.5%).
By 2040 the average reaches $22.61 (max $47.17, ROI 219.4%), and by 2050 the average is $48.81 with a max of $112.26 (ROI 589.4%). These figures are estimates, not guarantees, and actual results will vary with market conditions.
Tap a question to reveal the answer.
The 2030 forecast shows min $7.77, avg $12.04, max $20.17 with ROI 70.1% and sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages and ROIs (e.g., 2027 avg $10.27, ROI 45%; 2028 avg $10.61, ROI 49.8%; 2029 avg $12.13, ROI 71.4%; 2050 ROI 589.4%). These are estimates, not guarantees.
Yes. The 2050 max forecast is $112.26, which exceeds $100.
The 30-day trading range is $5.17 to $9.70.
Current price is $7.08 and market cap is $65.71M.
eXoZymes, Inc. Community Discussion
0Share your eXoZymes, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.